Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 169-175 , June 2010

Exploring the genetic architecture of neonatal hyperbilirubinemia

  • Jon F. Watchko

      Affiliations

    • Division of Newborn Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Magee-Women's Research Institute, Pittsburgh, PA 15213, USA
    • Corresponding Author InformationCorresponding author. Address: Division of Newborn Medicine, Department of Pediatrics, Magee-Women's Hospital, 300 Halket Street, Pittsburgh, PA 15213, USA. Tel.: +1 412 641 1834; fax: +1 412 641 5313.
    • ,
  • Zhili Lin

      Affiliations

    • Perkin Elmer Genetics, 90 Emerson Lane, Bridgeville, PA 15017, USA

References 

  1. Watchko JF. Indirect hyperbilirubinemia in the neonate. In:  Maisels MJ,  Watchko J editor. Neonatal jaundice. Amsterdam: Harwood; 2000;p. 51–66
  2. Maisels MJ, Kring E. Length of stay, jaundice and hospital readmission. Pediatrics. 1998;101:995–998
  3. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004;24:650–662
  4. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the Pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009;29:S25–S45
  5. Perlstein MA. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am. 1960;7:665–687
  6. Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinemia in the era of genomics. Semin Neonatol. 2002;7:143–152
  7. Watchko JF. Vigintiphobia revisited. Pediatrics. 2005;115:1747–1753
  8. Kaplan M, Hammerman C. Bilirubin and the genome: the hereditary basis of unconjugated neonatal hyperbilirubinemia. Curr Pharmacogenomics. 2005;3:21–42
  9. Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol. 2003;38:107–117
  10. Kadakol A, Ghosh SS, Sappal BS, et al. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler–Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000;16:297–306
  11. Kaplan M, Renbaum P, Levy-Lahad E, et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A. 1997;94:12128–12132
  12. Beutler E. G6PD deficiency. Blood. 1994;84:3613–3636
  13. Huang CS, Huang MJ, Lin MS, et al. Genetic factors related to unconjugated hyperbilirubinemia amongst adults. Pharmacogenet Genomics. 2005;15:43–50
  14. Huang MJ, Kua KE, Teng HC, et al. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004;56:682–689
  15. Watchko JF, Lin Z, Clark RH, Kelleher AS, Walker W, Spitzer AR. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics. 2009;124:e868–e877
  16. Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104:1198–1203
  17. Kidd KK, Kidd JR. Human genetic variation of medical significance. In:  Stearns SC,  Koella JC editor. Evolution in health and disease. New York: Oxford University Press; 2008;p. 51–62
  18. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet. 2002;3:872–882
  19. Ebbesen F, Mortensen BB. Difference in plasma bilirubin concentration between monozygotic and dizygotic newborn twins. Acta Paediatr. 2003;92:569–573
  20. Tan KL. Neonatal jaundice in twins. Aust Paediatr J. 1980;16:70–72
  21. Dolan SM, Moore C. Linking family history in obstetric and pediatric care: assessing risk for genetic disease and birth defects. Pediatrics. 2007;120:S66–S70
  22. Keren R, Luan X, Friedman S, et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near term infants. Pediatrics. 2008;121:e170–e179
  23. Gale R, Seidman DS, Dollberg S, Stevenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr. 1990;10:82–86
  24. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140–1147
  25. Khoury MJ, Calle EE, Joesoef RM. Recurrence risk of neonatal hyperbilirubinemia in siblings. Am J Dis Child. 1988;142:1065–1069
  26. Nielsen H, Hasse P, Blaabjerg J, Stryhn H, Hilden J. Risk factors and sib correlation in physiological neonatal jaundice. Acta Paediatr Scand. 1987;76:504–511
  27. Newman TB, Easterling MJ, Goldman ES, Stevenson DK. Laboratory evaluation of jaundice in newborns. Am J Dis Child. 1990;144:364–368
  28. American Academy of Pediatrics , Subcommittee on Hyperbilirubinemia . Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316
  29. Ho NK. Neonatal jaundice in Asia. Baillière's Clin Hematol. 1992;5:131–142
  30. Huang CS, Luo GA, Huang MJ, Yu SC, Yang SS. Variations of the bilirubin uridine-glucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics. 2000;10:539–544
  31. Huang CS, Chang PF, Huang MJ, et al. Relationship between bilirubin UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Pediatr Res. 2002;52:601–605
  32. Yamamoto K, Sato H, Fujiyama Y, et al. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler–Najjar syndrome type II. Biochim Biophys Acta. 1998;1406:267–273
  33. Gourley GR. Disorders of bilirubin metabolism. In:  Suchy FJ editors. Liver disease in children. St Louis: Mosby-Yearbook; 1994;p. 401–413
  34. Koiwai O, Nishizawa M, Hasada K, et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet. 1995;4:1183–1186
  35. Zhou YY, Lee LY, Ng SY, et al. UGT1A1 haplotype mutation among Asians in Singapore. Neonatology. 2009;96:150–155
  36. Pasanen M, Neuvonen PJ, Niemi M. Global analysis of genetic variation in SLCO1B1. Pharmacogenomics. 2008;9:19–33
  37. Prachukthum S, Nunnarumit P, Pienvichit P, et al. Genetic polymorphisms in Thai neonates with hyperbilirubinemia. Acta Paediatr. 2009;98:1106–1110
  38. Chou SC, Palmer RH, Ezhuthachan S, et al. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model. Pediatrics. 2003;112:1264–1273
  39. Newman TB, Kuzniewicz , Liljestrand P, Wi S, McCulloch C, Escobar GJ. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines. Pediatrics. 2009;123:1352–1359
  40. Beutler E, Gelbert T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism. Proc Natl Acad Sci U S A. 1998;95:8170–8174
  41. Maisels MJ, Gifford K, Antle CE, et al. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics. 1988;81:505–511
  42. Sieg A, Arab L, Schlierf G, et al. Prevalence of Gilbert's syndrome in Germany. Dtsch Med Wochenschr. 1987;112:1206–1208
  43. Diamond LK, Vaughn VC, Allen FH. Erythroblastosis fetalis III. Prognosis in relation to clinical and serologic manifestations at birth. Pediatrics. 1950;6:630–637
  44. Armitage P, Mollison PL. Further analysis of controlled trials of treatment of haemolytic disease of the newborn. J Obstet Gynaecol Br Emp. 1953;60:605–620
  45. Walker W, Mollison PL. Haemolytic disease of the newborn: deaths in England and Wales during 1953 and 1955. Lancet. 1957;1:1309–1314
  46. Crosse VM. The incidence of kernicterus (not due to haemolytic disease) among premature babies. In:  Sass-Kortsak A editors. Kernicterus. Toronto: University of Toronto Press; 1961;p. 4–9
  47. Johnson L, Garcia ML, Figueroa E, et al. Kernicterus in rats lacking glucuronyl transferase. Am J Dis Child. 1961;101:322–349
  48. Cannon C, Daood MJ, Watchko JF. Sex specific regional brain bilirubin content in hyperbilirubinemic Gunn rat pups. Biol Neonate. 2006;90:40–45
  49. Becu-Villabos D, Gonzalez Iglesias A, Diaz-Torga G, et al. Brain sexual differentiation and gonadotropins secretion in the rat. Cell Mol Neurobiol. 1997;17:699–715
  50. Clarke DJ, Moghrabi N, Monaghan G, et al. Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinemias. Clin Chim Acta. 1997;266:63–74
  51. Perera MA, Innocenti F, Ratain MJ. Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms. Are we there yet?. Pharmacotherapy. 2008;28:755–768
  52. Kawade N, Onishi S. The prenatal and postnatal development of UDP glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in human liver. Biochem J. 1981;196:257–260
  53. Coughtrie MW, Burchell B, et al. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol. 1988;34:729–735
  54. Sugatani J, Mizushima K, Osabe M, et al. Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 promoter. Naunyn-Schmiedebergs Arch Pharmacol. 2008;377:597–605
  55. Valaes T. Bilirubin metabolism: review and discussion of inborn errors. Clin Perinatol. 1976;3:177–209
  56. Crigler JF, Najjar VA. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics. 1952;10:169–180
  57. Gilbert A, Lereboullet P. La cholemia simple familiale. Semaine Med. 1901;21:241–243
  58. Bosma PJ, Roy Chowdhury J, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171–1175
  59. Powell LW, Hemingway E, Billing BH, et al. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): a study of 42 families. N Engl J Med. 1967;277:1108–1112
  60. Innocenti F, Undevia SD, Iyer L, et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol. 2004;22:1382–1388
  61. Odell GB. Neonatal hyperbilirubinemia. New York: Grune & Stratton; 1980;
  62. Oski FA. Unconjugated hyperbilirubinemia. In:  Avery ME,  Taeusch HW editor. Diseases of the newborn. Philadelphia: WB Saunders; 1984;p. 630–632
  63. Bancroft JD, Kreamer B, Gourley GR. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr. 1998;132:656–660
  64. Roy-Chowdury N, Deocharan B, Bejjanki HR, et al. Presence of the genetic marker for Gilbert syndrome is associated with increased level and duration of neonatal jaundice. Acta Paediatr. 2002;91:100–102
  65. Agrawal SK, Kumar P, Rathi R, et al. UGT1A1 gene polymorphisms in North Indian neonates presenting with unconjugated hyperbilirubinemia. Pediatr Res. 2009;65:675–680
  66. Galanello R, Cipollina MD, Carboni G, et al. Hyperbilirubinemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert's syndrome. Eur J Pediatr. 1999;158:914–916
  67. Ulgenalp A, Duman N, Schaefer FV, et al. Analyses of polymorphism for UGT1*1 exon 1 promoter in neonates with pathologic and prolonged jaundice. Biol Neonate. 2003;83:258–262
  68. Iolascon A, Faienza MF, Moretti A, Perrotta S. Miraglia del Giudice E. UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary pherocyctosis. Blood. 1998;91:1093
  69. Maruo Y, Nishizawa K, Sato H, et al. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics. 2000;106:e59
  70. Monaghan G, McLellan A, McGeehan A, et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr. 1999;134:441–446
  71. Akaba K, Kimura T, Sasaki A, et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int. 1998;46:21–26
  72. Boo NY, Wong FL, Wang MK, Othman A. Homozygous variant of UGT1A1 gene mutation and severe neonatal hyperbilirubinemia. Pediatr Int. 2009;51:488–493
  73. Sugatani J, Yamakawa K, Yoshinari K, et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun. 2002;292:492–497
  74. Lin Z, Fontaine J, Watchko JF. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics. 2008;122:el56–el62
  75. Maruo Y, Addario CD, Mori A, et al. Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as principal cause of Gilbert syndrome. Hum Genet. 2004;115:525–526
  76. Jirsa M, Petrasek J, Vitek L. Linkage between A(TA)7TAA and −3279T→G mutations in UGT1A1 is not essential for pathogenesis of Gilbert syndrome. Liver Int. 2006;26:1302–1303
  77. Costa E, Vieira E, dos Santos R. The polymorphism c.−3279T→G in the phenobarbital responsive enhancer module of the bilirubin UDP-glucuronosyltransferase gene is associated with Gilbert syndrome. Clin Chem. 2005;51:2204–2206
  78. Sai K, Saeki M, Saito Y, et al. UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther. 2004;75:501–515
  79. Muraca M, Fevery J, Blanckaert N. Relationships between serum bilirubins and production and conjugation of bilirubin. Studies in Gilbert's syndrome, Crigler–Najjar disease, hemolytic disorders and rat models. Gastroenterology. 1987;92:309–317
  80. Spivak W, DiVenuto D, Yuey W. Non-enzymatic hydrolysis of bilirubin mono- and diglucuronide to unconjugated bilirubin in model and native bilirubin systems. Biochem J. 1987;242:323–329
  81. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730–733
  82. Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr Suppl. 1994;394:58–76
  83. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol. 2004;28:356–364
  84. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008;111:16–24
  85. Lin Z, Fontaine JM, Freer DE, et al. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab. 2005;86:212–219
  86. Cui Y, Konig J, Leier I, et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276:9626–9630
  87. Daood MJ, Watchko JF. Ontogeny of human and murine solute carrier organic anion transporter 1B1 (SLCO1B1) expression in liver. EPAS. 2006;59:5575;484
  88. Lin R, Wang X, Wang Y, et al. Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian polulations. Hum Mutat. 2009;30:609–615
  89. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med. 2004;37:1097–1104
  90. Endler G, Exner M, Schillinger M, et al. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost. 2004;91:155–161
  91. Yamda N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet. 2000;66:187–195
  92. Kanai M, Akaba K, Sasaki A, et al. Neonatal hyperbilirubinemia in Japanese neonates: analysis of the heme oxygenase-1 gene and fetal hemoglobin composition in cord blood. Pediatr Res. 2003;54:165–171
  93. Immenschuh S, Shan Y, Kroll H, et al. Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia. Pediatrics. 2007;119:e764–e767
  94. Kadakol A, Sappal BS, Ghosh SS, et al. Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinemia and may lead to neonatal kernicterus. J Med Genet. 2001;38:244–249
  95. Vockley J, Rinaldo P, Bennett MJ, Matern D, Vladutiu GD. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab. 2000;71:10–18
  96. Zangen S, Kidron D, Gelbart T, Roy-Chowdury N, Wang X, Kaplan M. Fatal kernicterus in a girl deficient in glucose-6-phosphate dehydrogenase: a paradigm of synergistic heterozygosity. J Pediatr. 2009;154:616–619
  97. Lin JP, Cupples LA, Wilson PW, Heard-Costa N, O'Donnell CJ. Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomewide scan in the Framingham study. Am J Hum Genet. 2003;72:1029–1034
  98. Hunt SC, Wu LL, Hopkins PN, Williams RR. Evidence for a major gene elevating serum bilirubin concentration in Utah pedigree. Arterioscler Thromb Vasc Biol. 1996;16:912–917
  99. Ki CS, Lee KA, Lee SY, et al. Haplotype structure of the UDP-glucuronosyltransferase A1A (UGT1A1) gene and its relationship to serum total bilirubin concentration in a male Korean population. Clin Chem. 2003;49:2078–2081
  100. Guillemette C, Levesque E, Harvey M, Bellemare J, Menard V. UGT genomic diversity: beyond gene duplication. Drug Metab Rev. 2009 Sep 30;(Epub ahead of print)
  101. Gagnon JF, Bernard O, Villeneuve L, Tetu B, Guillemette C. Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. Clin Cancer Res. 2006;12:1850–1858
  102. Aono S, Yamada Y, Keino H, et al. Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler–Najjar syndrome type II. Biochem Biophys Res Commun. 1993;197:1239–1244
  103. Sutomo R, Laosombat V, Sadewa AH, et al. Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. Pediatr Int. 2002;44:427–432
  104. Costa E, Vieira E, Martins M, et al. Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler–Najjar syndromes. Blood Cells Mol Dis. 2006;36:91–97
  105. Farheen S, Sengupta S, Santra A, et al. Gilbert's syndrome: high frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene from bilirubin UDP-glucuronosyltransferase 1 gene. World J Gastroenterol. 2006;12:2269–2275
  106. Strassburg CP, Kalthoff S, Ehmer U. Variability and function of family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A). Crit Rev Clin Lab Sci. 2008;45:485–530
  107. Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, Di Rienzo A. Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics. 1999;9:591–599
  108. Haverfield EV, McKenzie CA, Forrester T, et al. UGT1A1 variation and gallstone formation in sickle cell disease. Blood. 2005;105:968–972
  109. Han JY, Lim HS, Shin ES, et al. Comprehensive analysis of UGT1A1 polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J Clin Oncol. 2006;24:2237–2244
  110. Saito Y, Maekawa K, Ozawa S, Sawada J. Genetic polymorphisms and haplotypes of major drug metabolizing enzymes in East Asians and their comparison with other ethnic populations. Curr Pharmacogenomics. 2007;5:49–78

PII: S1744-165X(09)00110-3

doi: 10.1016/j.siny.2009.11.003

Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 169-175 , June 2010

Article Tools

* Image Usage & Resolution